Physician profile
Ernest Eugene Lissy
NPI 1013998475
$2,409.27
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,235 · 2022: $1,175.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $348.19 | 2021-2022 | |
| Daiichi Sankyo INC. | $320.87 | 2021-2022 | |
| Lilly USA, LLC | $283.19 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $250.41 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $223.40 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $166.46 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $118.80 | 2022 | |
| Amarin Pharma, INC. | $95.42 | 2021 | |
| Janssen Pharmaceuticals, INC | $92.79 | 2021-2022 | |
| Pfizer INC. | $66.07 | 2021-2022 | |
| Philips North America LLC | $61.98 | 2021 | |
| Glaxosmithkline, LLC. | $59.16 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $53.24 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $51.70 | 2022 | |
| Novo Nordisk INC | $41.95 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $33.39 | 2022 | |
| Aspira Women'S Health INC | $31.40 | 2022 | |
| Sanofi Pasteur INC. | $27.48 | 2022 | |
| Xeris Pharmaceuticals, INC. | $22.25 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.91 | 2022 | |
| Upsher-Smith Laboratories LLC | $16.00 | 2021 | |
| Amgen INC. | $15.85 | 2021 | |
| Esperion Therapeutics, INC. | $12.36 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ernest Lissy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.